Preparation and characterization of folic acid functionalized bioactive glass for targeted delivery and sustained release of methotrexate

Abstract

We have successfully prepared a novel targeted drug delivery system, composed of folic acid (FA) as targeting molecule, methotrexate (MTX) as anticancer drug, and bioactive glass (BG) as carrier. The BG nanoparticles were synthesized by sol‐gel method with the dodecylamine as template. The surface of BG nanoparticles was grafted with amino groups by (3‐aminopropyl) triethoxysilane, then, FA and MTX were covalently conjugated to the surface of modified BG through amidation reaction, so FA functionalized BG (BG‐FA) and targeted drug delivery system (MTX‐BG‐FA) were prepared. The physicochemical properties of BG, BG‐NH2, and BG‐FA were characterized by various methods, such as X‐ray diffraction, scanning electron microscopy, transmission electron microscopy, Fourier transform infrared spectroscopy, ultraviolet–visible, and so on. Moreover, the drug release results showed that the MTX‐BG‐FA had sustained release property because of the peptide bond between MTX and BG‐FA. And the cytocompatibility evaluation demonstrated that the BG and BG‐FA were biocompatible and BG‐FA even could promote cell proliferation, while the MTX‐BG‐FA had high cytotoxicity owning to the sustained release of anticancer drug. From the above, it could be concluded that MTX‐BG‐FA could kill tumor cells targetedly and sustainedly, which made it a good cancer targeted therapy material. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 107A: 319–329, 2019.

Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent

“…The modification of bioactive glass surfaces with folic acid has been used to exploit the molecular targeting of tumor cells that overexpress folic acid receptors. This strategy facilitates the internalization of the glass by cancer cells, thereby enhancing the anti-tumor properties of drug [ 236 ].…”